Table 4.

Comparisons of LC3-l, LC3-ll, LC3-ll/LC3-l, p62, and nephrin in different groups after 8 weeks.

Group	N	LC3-l	LC3-ll	LC3-ll/LC3-l	p62	Nephrin
Normal	7	1.00 ± 0.00	1.00 ± 0.00	1.00 ± 0.00	1.00 ± 0.00	1.00 ± 0.00
Model	7	1.00 ± 0.22	1.55 ± 0.18∗∗	1.61 ± 0.33∗∗	1.58 ± 0.19∗∗	0.60 ± 0.08∗∗
Keluoxin	7	0.88 ± 0.15	1.28 ± 0.22#	1.17 ± 0.39##	1.21 ± 0.21#	0.94 ± 0.09##
Irbesartan	7	1.18 ± 0.37	1.30 ± 0.26#	1.49 ± 0.29#	1.19 ± 0.18##	0.86 ± 0.15##

Data were presented as means ± SD.^∗P < 0.05 and ^∗∗P < 0.01 versus the normal group; ^#P < 0.05 and ^##P < 0.01 versus the model group.